IQVIA Mar 31, 2026 The evolution of pharma engagement as AI becomes a front door to medical information - IQVIA
FierceBiotech Mar 26, 2026 Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA
IQVIA Mar 13, 2026 Expanding Options for Emerging Biopharma in the U.S.: A conversation with Meg Hooton, IQVIA Biotech - IQVIA